Royalty Pharma Plc (RPRX)
55.62
+0.76
(+1.39%)
USD |
NASDAQ |
Jun 09, 16:00
55.62
0.00 (0.00%)
After-Hours: 18:53
Royalty Pharma Research and Development Expense (Quarterly) : 39.79M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.495B |
| ANI Pharmaceuticals, Inc. | 10.60M |
| Corcept Therapeutics, Inc. | 66.26M |
| Elanco Animal Health, Inc. | 97.00M |
| Harmony Biosciences Holdings, Inc. | 69.38M |